Sobre este episodio
Iago Jooooorge, Marcela Belleza e Eduarda Bauer atualizam o episódio 102 de osteoporose em 5 clinicagens: como avaliar o risco de fratura? Como e quando iniciar o ??tratamento após fratura? Como continuar o tratamento depois dos medicamentos anabólicos? ??Quando e como acompanhar as "férias" de bisfosfonatos? Como tratar homens com osteoporose? Vote no TdC no prêmio Melhores Podcasts do Brasil (prêmio MPB). Estamos na categoria Ciência! https://www.premiompb.com.br/ Referências: Site da ABRASSO - https://abrasso.org.br/ Frax Plus https://www.fraxplus.org/frax-plus https://www.tadeclinicagem.com.br/guia/198/tratamento-farmacologico-de-osteoporose-primaria/ Richard Eastell, Clifford J Rosen, Dennis M Black, Angela M Cheung, M Hassan Murad, Dolores Shoback, Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 5, May 2019, Pages 1595–1622, https://doi.org/10.1210/jc.2019-00221 Silva BC, Madeira M, d'Alva CB, et al. Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO). Arch Endocrinol Metab. 2022;66(5):591-603. doi:10.20945/2359-3997000000522 Radominski SC, Bernardo W, Paula AP, et al. Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Rev Bras Reumatol Engl Ed. 2017;57 Suppl 2:452-466. doi:10.1016/j.rbre.2017.07.001 Gregson, C.L., Armstrong, D.J., Bowden, J. et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17, 58 (2022). https://doi.org/10.1007/s11657-022-01061-5 El Miedany, Y., Toth, M., Elwakil, W. et al. Post-Fracture Care Program: Pharmacological Treatment of Osteoporosis in Older Adults with Fragility Fractures. Curr Osteoporos Rep 21, 472–484 (2023). https://doi.org/10.1007/s11914-023-00791-w Wang CY, Fu SH, Yang RS, Chen LK, Shen LJ, Hsiao FY. Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: A nationwide cohort study. Bone. 2020;138:115452. doi:10.1016/j.bone.2020.115452 Camacho PM, Petak SM, Binkley N, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE. Endocr Pract. 2020;26(Suppl 1):1-46. doi:10.4158/GL-2020-0524SUPPL Ramchand SK, Leder BZ. Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis. J Clin Endocrinol Metab. 2024;109(2):303-311. doi:10.1210/clinem/dgad496 Chandran M. The why and how of sequential and combination therapy in osteoporosis. A review of the current evidence. Arch Endocrinol Metab. 2022;66(5):724-738. doi:10.20945/2359-3997000000564
